References
Póvoa P, Salluh JIF (2012) Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review. Ann Intensive Care 2:32. https://doi.org/10.1186/2110-5820-2-32
Vincent JL, Mercan D (2000) Dear sirs, what is your PCT? Intensive Care Med 26:1170–1171. https://doi.org/10.1007/s001340000605
Klein Klouwenberg PMC, Cremer OL, van Vught LA et al (2015) Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care 19:1–8. https://doi.org/10.1186/s13054-015-1035-1
Nora D, Salluh J, Martin-Loeches I, Póvoa P (2017) Biomarker-guided antibiotic therapy—strengths and limitations. Ann Transl Med 5:208–208. https://doi.org/10.21037/atm.2017.04.04
Póvoa P, Coelho L, Bos LD (2019) biomarkers in pulmonary infections. Clin Pulm Med 26:118–125. https://doi.org/10.1097/CPM.0000000000000322
Póvoa P (2008) Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Curr Opin Infect Dis 21:157–162. https://doi.org/10.1097/QCO.0b013e3282f47c32
Vincent JL (1997) Dear SIRS, I’m sorry to say that I don’t like you. Crit Care Med 25:372–374. https://doi.org/10.1097/00003246-199702000-00029
Salluh JIF, Souza-Dantas VC, Póvoa P (2017) The current status of biomarkers for the diagnosis of nosocomial pneumonias. Curr Opin Crit Care 23:391–397. https://doi.org/10.1097/MCC.0000000000000442
Marshall JC, Vincent JL, Fink MP et al (2003) Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the fifth Toronto sepsis roundtable, Toronto, Ontario, Canada, October 25–26, 2000. Crit Care Med 31:1560–1567. https://doi.org/10.1097/01.CCM.0000065186.67848.3A
Poole S, Kidd SP, Saeed K (2018) A review of novel technologies and techniques associated with identification of bloodstream infection etiologies and rapid antimicrobial genotypic and quantitative phenotypic determination. Expert Rev Mol Diagn 18:543–555. https://doi.org/10.1080/14737159.2018.1480369
Shapiro NI, Trzeciak S, Hollander JE et al (2009) A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 37:96–104. https://doi.org/10.1097/CCM.0b013e318192fd9d
Parlato M, Philippart F, Rouquette A et al (2018) Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: the CAPTAIN prospective multicenter cohort study. Intensive Care Med 44:1061–1070. https://doi.org/10.1007/s00134-018-5228-3
Salluh JIF, Nobre V, Povoa P (2014) Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers. Crit Care 18:1–3. https://doi.org/10.1186/cc13870
Lisboa T, Salluh J, Povoa P (2018) Do we need new trials of procalcitonin-guided antibiotic therapy? Crit Care 22:17. https://doi.org/10.1186/s13054-018-1948-6
Pepper DJ, Sun J, Rhee C et al (2019) Procalcitonin-guided antibiotic discontinuation and mortality in critically Ill adults: a systematic review and meta-analysis. Chest 155:1109–1118. https://doi.org/10.1016/j.chest.2018.12.029
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare no conflicts of interest related to this topic.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Póvoa, P., Salluh, J.I.F. & Lisboa, T. Biomarkers in the ICU: less is more? Not sure. Intensive Care Med 47, 101–103 (2021). https://doi.org/10.1007/s00134-020-06077-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-020-06077-4